Lilly psoriasis drug impresses; battle nears with Amgen, Novartis

(Reuters) - An experimental new psoriasis treatment from Eli Lilly and Co proved superior to Amgen Inc's blockbuster Enbrel, drawing it closer to a potential marketing battle with new products being developed by Amgen and Novartis AG.

Source: Reuters: Health - August 21, 2014 Category: Consumer Health News Tags: healthNews Source Type: news